Overview

COMbination of Clopidogrel and Aspirin for Prevention of Early REcurrence in Acute Atherothrombotic Stroke

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
Primary objective: - Comparison of efficacy of the combination therapy (clopidogrel plus aspirin) and the aspirin alone (main comparison) to prevent any recurrent ischemic lesion . Secondary objectives: - Comparison of Modified Rankin scale (mRS) scores; - Comparison of the Incidence of all kinds of stroke and vascular death; - Comparison of the Incidence of bleeding episodes (major and minor) and symptomatic intracerebral hemorrhages during the follow-up period.
Phase:
Phase 4
Details
Lead Sponsor:
Sanofi
Collaborator:
Bristol-Myers Squibb
Treatments:
Aspirin
Clopidogrel
Ticlopidine